(−)-Nicotine hemisulfate salt
SIGMA/N1019 - ≥95% (TLC), ~35 % (w/v) in H2O (based on free base)
Synonym: (−)-1-Methyl-2-(3-pyridyl)pyrrolidine
CAS Number: 65-30-5
Empirical Formula (Hill Notation): C20H28N4 · H2O4S
Molecular Weight: 422.54
MDL Number: MFCD00148918
Linear Formula: (C10H14N2)2 · H2SO4
Product Type: Chemical
| assay | ≥95% (TLC) |
| color | dark brown |
| concentration | ~35 % (w/v) in H2O (based on free base) |
| form | liquid |
| InChI | 1S/2C10H14N2.H2O4S/c2*1-1 |
| InChI key | IECQULMJVNSKDB-RCWTXCDDSA |
| Quality Level | 100 ![]() |
| SMILES string | OS(O)(=O)=O.CN1CCC[C@H]1c |
| Analysis Note: | Mixture of nicotine base and nicotine sulfate. |
| Application: | (−)-Nicotine hemisulfate salt has been used to study the influence of nicotine on the severity of choroidal neovascularization (CNV). It also has been used as a natural nectar alkaloid to study the effect of self-medication in bumblebees. |
| Biochem/physiol Actions: | Prototype nicotinic acetylcholine receptor agonist; naturally occurring isomer. |
| Disclaimer: | Shelf-life of the solution as supplied is at least six years when stored at room temperature. |
| General description: | Nicotine is found in the leaves of Nicotiana species. It binds to nicotinic acetylcholine receptors and inhibits endogenous neurotransmitters. Nicotine is associated with lung cancer development and reduces the efficiency of chemotherapeutic agents. It is used to treat Alzheimer′s and Parkinson′s disease. |
| Packaging: | 25, 100 mL in glass bottle |
| Symbol | ![]() GHS06,GHS09 |
| Signal word | Danger |
| Hazard statements | H301 - H310 + H330 - H411 |
| Precautionary statements | P260 - P262 - P273 - P280 - P302 + P352 + P310 - P304 + P340 + P310 |
| Hazard Codes | T+,N |
| Risk Statements | 26/27/28-51/53 |
| Safety Statements | 28-36/37-45-61 |
| RIDADR | UN 1658 6.1 / PGII |
| WGK Germany | WGK 3 |
| Purity | ≥95% (TLC) |
| UNSPSC | 12352210 |



